Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,364 | 1 | 58.2% |
| Grant | $1,000 | 1 | 17.3% |
| Food and Beverage | $991.52 | 16 | 17.2% |
| Travel and Lodging | $406.10 | 2 | 7.0% |
| Education | $14.69 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $3,545 | 3 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,618 | 7 | $0 (2018) |
| Mirum Pharmaceuticals, Inc. | $453.80 | 8 | $0 (2024) |
| ALBIREO PHARMA, INC. | $126.15 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.87 | 1 | $0 (2022) |
| Retrophin, Inc. | $14.69 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,619 | 6 | Ipsen Biopharmaceuticals, Inc ($3,545) |
| 2023 | $379.68 | 5 | Mirum Pharmaceuticals, Inc. ($379.68) |
| 2022 | $145.02 | 2 | ALBIREO PHARMA, INC. ($126.15) |
| 2018 | $632.78 | 7 | Merck Sharp & Dohme Corporation ($618.09) |
| 2017 | $1,000 | 1 | Merck Sharp & Dohme Corporation ($1,000) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,364.00 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $52.00 | General |
| Category: Gastroenterology | ||||||
| 09/13/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Alagille syndrome | ||||||
| 07/15/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $128.71 | General |
| Category: Gastroenterology | ||||||
| 06/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Alagille syndrome | ||||||
| 02/23/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $37.67 | General |
| Category: Alagille syndrome | ||||||
| 12/06/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $46.14 | General |
| Category: Alagille syndrome | ||||||
| 11/12/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $40.35 | General |
| Category: Alagille syndrome | ||||||
| 07/12/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $121.48 | General |
| Category: Alagille syndrome | ||||||
| 05/30/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $145.73 | General |
| Category: Alagille syndrome | ||||||
| 05/18/2023 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Alagille syndrome | ||||||
| 11/29/2022 | ALBIREO PHARMA, INC. | Bylvay (Drug) | Food and Beverage | In-kind items and services | $126.15 | General |
| Category: Gastroenterology | ||||||
| 07/29/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $14.69 | General |
| Category: Hepatology | ||||||
| 01/11/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/11/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/11/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/10/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Travel and Lodging | In-kind items and services | $215.97 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/10/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Travel and Lodging | In-kind items and services | $190.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/10/2018 | Merck Sharp & Dohme Corporation | MK-5172 (Drug) | Food and Beverage | In-kind items and services | $87.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/08/2017 | Merck Sharp & Dohme Corporation | — | Grant | Cash or cash equivalent | $1,000.00 | General |
About James Squires
James Squires is a Pediatric Gastroenterology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1104090281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Squires has received a total of $5,776 in payments from pharmaceutical and medical device companies, with $3,619 received in 2024. These payments were reported across 21 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,364).
Practice Information
- Specialty Pediatric Gastroenterology
- Location Pittsburgh, PA
- Active Since 04/18/2008
- Last Updated 06/15/2021
- Taxonomy Code 2080P0206X
- Entity Type Individual
- NPI Number 1104090281
Products in Payments
- Bylvay (Drug) $3,671
- MK-5172 (Drug) $618.09
- Livmarli (Drug) $453.80
- LIVTENCITY (Drug) $18.87
- (820) Cholbam (Drug) $14.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Gastroenterology Doctors in Pittsburgh
Patrick Mckiernan
Pediatric Gastroenterology — Payments: $44,288
Dr. Whitney Sunseri, M.d,, M.D,
Pediatric Gastroenterology — Payments: $1,587
Vibha Sood, M.d, M.D
Pediatric Gastroenterology — Payments: $671.00
Jeffrey Rudolph, M.d, M.D
Pediatric Gastroenterology — Payments: $338.90
Arvind Srinath
Pediatric Gastroenterology — Payments: $189.33
Micaela Connelly, Crnp, CRNP
Pediatric Gastroenterology — Payments: $175.93